CLOSED
GET A PIECE OF CALIBRE BIOMETRICS
Show more
Udi Meirav • CEO and Founder
Read More
Raviv Shefet • Chief Financial Officer
Read More
David Ierardi • Chief Operating Officer
Read More
Overview
Respiratory data has been enormously interesting to medical science but out of reach for most people. At Calibre, we aim to provide an accessible way for anyone to track and collect this data whenever and wherever they would like to. The implications are groundbreaking and amazing.
Combining established respiratory science with breakthrough technology, we believe Calibre empowers users to take charge of their metabolism, respiratory wellness, and much more.
Through our game-changing design and technology, Calibre enables respiratory data access to anyone, simply, on a cloud-enabled app. In other words, we are unlocking a hidden trove of personal metabolic and physiological data for millions.
THE Problem & OUR solution
Breath data has been historically only accessible for professional use in laboratory settings, utilizing expensive, cumbersome, complex equipment.
Calibre solves all these issues, thereby unleashing a whole new market.
Proven science shows all our calories are “burned” using oxygen and producing CO2 - that’s breath! Calibre makes this established insight available to everybody - accurately tracking calories used per minute by measuring the oxygen and C02 in exhaled breath. It can even distinguish fat burn from carb burn, isn’t that cool? And perhaps most remarkable, this works in any activity and for any body type. All on your phone, anytime you want.
We are aware that respiratory monitoring machines have been available for years, but they can cost from $10k upwards to $100k - where at Calibre our device is under $400 and usable anywhere. Currently, we are engaged in a B2C model that provides 1:1 sales; however, it is our goal to also offer our products at a large scale through institutions, sports programs, and various partnerships.
Calibre provides an easy way for breath data to be collected securely in real-time to the cloud. As such, we feel Calibre can become extremely beneficial in medical and clinical settings in the not-too-distant future. Calibre could provide caregivers remote patient monitoring capabilities for a range of conditions and purposes ranging from pulmonary and cardiovascular health to sleep and neurological issues. We also believe that Calibre can be a powerful tool for clinical research on a new scale, in terms of what and how participants, can be studied using Calibre devices. At the moment Calibre is not an FDA-approved medical device, but we are planning to apply for FDA clearance in the near future.
The market & Our Traction
In this expanding market, we feel there has been a glaring absence of products to monitor and track respiratory data. Calibre's technology has the potential to fill that gap and offer key insights through the data collected.
The global wearable technology market size is projected to grow at a compound annual growth rate of 13.89% to reach around $392.4 Billion during the forecast period of 2022 to 2030 (source), and wearable devices specifically in consumer applications could skyrocket up to $212.67 Billion by 2029 (source).
Calibre aims to be an industry leader in these growing markets, and we believe we have made significant headway towards that goal. In anticipation of such potential, we have filed multiple patents (8 pending, one already issued).
Here’s a look at more of our traction...
WHY INVEST
We feel that Calibre is poised to disrupt the wearables and digital health market, and believe that our technology's application can expand tremendously with the financial support we need to get there.
Our longer-term vision is to “get serious” about the medical opportunities - moving towards FDA certification, hiring the right experts, and, above all, engaging the medical community.
Calibre is bringing something unique, novel, affordable, and accessible to the market - we believe everyone can have access to their respiratory data through user-friendly wearable technology. Join in on the mission and invest today!
Maximum Number of Shares Offered subject to adjustment for bonus shares
*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.
Investment Incentives and Bonuses*
Time-Based:
Friends and Family Early Birds
Invest within the first 96 hours and receive 20% bonus shares.
Super Early Bird Bonus
Invest within the first week and receive 15% bonus shares.
Early Bird Bonus
Invest within the first three weeks and receive 10% bonus shares.
Amount-Based:
$1000 + / Supporter
Invest $1,000 and receive 2% Bonus Shares.
$2,500+ | VIP
Invest $2,500 + and receive 5% Bonus Shares.
$5,000 + | VIP + 10 % Bonus Shares
Invest $5,000+ and receive 10 % Bonus Shares, Free product.
$10,000+ | VIP Gold
Invest $10,000+ and receive 15% Bonus Shares, Free product, coaching session with Sean (Co-Founder/Master Instructor).
$25,000+ | VIP Platinum
Invest $25,000+ and receive 20% Bonus Shares + Private zoom call with Chief Executive Officer, Free product, coaching session with Sean (Co-Founder/Master Instructor).
*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
Calibre Biometrics Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Class A Common Stock at $2.50 / share, you will receive 110 shares of Class A Common Stock, meaning you'll own 110 shares for $250. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.
Irregular Use of Proceeds
Members get an extra 10% shares in addition to rewards below!
Venture Club
Venture Club Members earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).
Supporter
Invest $1,000 and receive 2% Bonus Shares.
VIP
Invest $2,500 + and receive 5% Bonus Shares.
VIP + 10 % Bonus Shares
Invest $5,000+ and receive 10 % Bonus Shares, Free product.
VIP Gold
Invest $10,000+ and receive 15% Bonus Shares, Free product, coaching session with Sean (Co-Founder/Master Instructor).
VIP Platinum
Invest $25,000+ and receive 20% Bonus Shares + Private zoom call with Chief Executive Officer, Free product, coaching session with Sean (Co-Founder/Master Instructor).